Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 64Completed 20Active not recruiting 17Not yet recruiting 16Terminated 3Enrolling by invitation 3Withdrawn 2Suspended 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Hepatitis 1Fibrosis 1Epidural Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 28Carboplatin 18Cisplatin 15Nivolumab 13Pemetrexed 12Paclitaxel 11Specimen Handling 10Ipilimumab 10Gemcitabine 10venetoclax 8durvalumab 8atezolizumab 8Radiotherapy 8Radiosurgery 8Magnetic Resonance Spectroscopy 8Docetaxel 7Cyclophosphamide 7Biopsy 7fludarabine 6enzalutamide 6Bevacizumab 6tislelizumab 5tazemetostat 5X-Rays 5Trastuzumab 5Surveys and Questionnaires 5Practice Guidelines as Topic 5Interviews as Topic 5Injections 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Blood Specimen Collection × 90 days × Clear all
NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

Terminated
1,865 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT03846128 2026-04-14

BIOSUNTOX

University Hospital, Rouen

Terminated
6 enrolled
Genitourinary

Kidney Neoplasms

NCT05204290 2026-03-24

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
1 enrolled

Neoplasms, Epidural Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡